Alyeska Investment Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-14,200
Closed -$142K 475
2018
Q3
$142K Buy
+14,200
New +$142K ﹤0.01% 357